📅 Date: 13 March 2025
⏰ Time: 16:00 – 17:00 CET
📍 Location: Online
Securing Medicine Availability and Patient Access
Join the Healthcare Chain Institute (HCI) for a groundbreaking webinar focusing on ensuring the continuous supply of medicines and patient access. This event marks the launch of the HCI Patient Access & Continuous Supply Working Group, bringing together leading experts to tackle critical supply chain vulnerabilities and develop actionable, patient-centric solutions.
Why Attend?
- Explore Key Challenges: Dive into pressing issues like production transparency, supplier diversification, and stockpiling strategies.
- Learn Best Practices: Gain insights into risk mitigation and adaptive strategies for improving medicine availability.
- Engage with Stakeholders: Collaborate with healthcare providers, pharmaceutical manufacturers, logistics experts, regulators, and policy advisors.
- Shape Policy and Advocacy: Contribute to discussions on regulatory changes that promote secure and equitable patient access.
🎙️ Speakers and Agenda
Christa Wirthumer
Consultant – Ministry of Health Austria
Simon Tottman
Vice President, IQVIA, Strategic Partners and Supplier Relations Group
Pieter-Jan Desiere
ESMP-SMART Product Owner – Medicines and Medical Devices Shortages Officer at EMA
Domenico Di Giorgio
Head of Inspection & Certification Department – Italian Medicines Agency
Marco Farinelli
Director of Market Supply – AstraZeneca | Chair of the Supply Chain Working Group – EFPIA
Adrian van den Hoven
Director General – Medicines for Europe
Monika Derecque-Pois
Founding Partner – HCI
Charles Gloor
Founding Member – HCI
Andrew Richmond
Founding Member – HCI
Andrew Bonser
Founding Member – HCI
Click here to view the featured speakers and detailed agenda for the webinar.
Be Part of the Solution
This webinar is your opportunity to shape the future of patient access through collaboration, innovation, and actionable strategies. Join us on 13 March 2025 from 16:00 – 17:00 CET to make a difference in building resilient, transparent supply chains for uninterrupted medicine availability.